State Street’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$910K Buy
370,107
+10,229
+3% +$34.2K ﹤0.01% 3509
2025
Q4
$1.43M Buy
359,878
+22,478
+7% +$99.5K ﹤0.01% 3438
2025
Q3
$1.28M Buy
+337,400
New +$1.15M ﹤0.01% 3455
2024
Q3
Sell
-102,961
Closed -$172K 4316
2024
Q2
$172K Sell
102,961
-7,412
-7% -$13.2K ﹤0.01% 3863
2024
Q1
$205K Buy
110,373
+8,674
+9% +$16K ﹤0.01% 3870
2023
Q4
$193K Buy
101,699
+2,174
+2% +$3.25K ﹤0.01% 3907
2023
Q3
$131K Sell
99,525
-407,107
-80% -$894K ﹤0.01% 4042
2023
Q2
$1.51M Sell
506,632
-13,641
-3% -$43.8K ﹤0.01% 3495
2023
Q1
$1.8M Buy
520,273
+32,696
+7% +$158K ﹤0.01% 3371
2022
Q4
$2.04M Buy
487,577
+5,939
+1% +$22.5K ﹤0.01% 3368
2022
Q3
$1.93M Sell
481,638
-1,166
-0.2% -$8.85K ﹤0.01% 3425
2022
Q2
$5.46M Sell
482,804
-268,450
-36% -$3.22M ﹤0.01% 3060
2022
Q1
$12.2M Buy
751,254
+127,890
+21% +$3.28M ﹤0.01% 2715
2021
Q4
$29.5M Buy
623,364
+76,142
+14% +$4.57M ﹤0.01% 2182
2021
Q3
$39.7M Buy
547,222
+104,897
+24% +$7.59M ﹤0.01% 1983
2021
Q2
$37.1M Buy
442,325
+424,738
+2,415% +$28M ﹤0.01% 2068
2021
Q1
$852K Buy
17,587
+2,295
+15% +$125K ﹤0.01% 3655
2020
Q4
$721K Buy
+15,292
New +$602K ﹤0.01% 3607

Other funds holding NBP

State Street's NBP Position: Q1 2026 in Review

State Street increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 2.8% in Q1 2026, buying an estimated $34.2K and bringing the position to 370,107 shares worth $910K. The position accounts for ﹤0.01% of the portfolio, ranked #3509.

State Street first reported a position in NBP in Q4 2020 and has held it in 18 quarters since. The position peaked at $39.7M in Q3 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

  • State Street held 370,107 shares of NovaBridge Biosciences American Depositary Shares worth $910K as of Q1 2026.
  • State Street bought 10,229 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $34.2K.
  • NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3509 holding.
  • State Street first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and has held it in 18 quarters since.
  • State Street's NovaBridge Biosciences American Depositary Shares position peaked at $39.7M in Q3 2021.
  • 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.